Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas W Georgi

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Pediatric Blood & Cancer|May 27, 2023
Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphomaFriedrich Christian Franke, Adrian Damek, Jonas Steglich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2018
<sup>18</sup>F-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required?Thomas W Georgi, Regine Kluge, Lars Kurch, et al.
Scientific Reports|June 25, 2024
Hodgkin lymphoma: hypodense lesions in mediastinal massesAdrian Damek, Lars Kurch, Friedrich Christian Franke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 10, 2025
Quantitative Deauville Scoring to Uncover Prognostic Information from <sup>18</sup>F-FDG PET-Based Response Assessment: Data from the EuroNet-PHL-C1 TrialLars Kurch, Judith Landman-Parker, Thomas W Georgi, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Pediatric Blood & Cancer|May 27, 2023
Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphomaFriedrich Christian Franke, Adrian Damek, Jonas Steglich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2018
<sup>18</sup>F-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required?Thomas W Georgi, Regine Kluge, Lars Kurch, et al.
Scientific Reports|June 25, 2024
Hodgkin lymphoma: hypodense lesions in mediastinal massesAdrian Damek, Lars Kurch, Friedrich Christian Franke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 10, 2025
Quantitative Deauville Scoring to Uncover Prognostic Information from <sup>18</sup>F-FDG PET-Based Response Assessment: Data from the EuroNet-PHL-C1 TrialLars Kurch, Judith Landman-Parker, Thomas W Georgi, et al.
Pageof 2